Test tubes at our biofacility in Boston, MA
Manus Is Awarded A Phase I STTR Grant From The National Science Foundation For The Development Of A Novel Pathway For Terpenoid Biosynthesis
Press Release
12:00 p.m. EDT. June 15, 2013
Media Relations Contact
Frederik Bjoerndal, Vice President
Corporate Affairs and Marketing Communications
Manus Bio
Manus, a leader in metabolic engineering and synthetic biology, announced today that it has been awarded a prestigious National Science Foundation grant under the Small Business Technology Transfer (STTR) program. This Phase I award ($225,000) supports the design and engineering of a de novo pathway for terpenoid production. The full abstract for the project entitled “Overcoming Metabolic Pathway Limitations through De Novo Pathway Design for Terpenoid Biosynthesis” can be found at https://www.sbir.gov/sbirsearch/detail/683834.
Share this article:
Featured articles
Follow the transition, up close!
